These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 36924324)

  • 1. Glucose-Responsive Charge-Switchable Lipid Nanoparticles for Insulin Delivery.
    Liu Y; Wang Y; Yao Y; Zhang J; Liu W; Ji K; Wei X; Wang Y; Liu X; Zhang S; Wang J; Gu Z
    Angew Chem Int Ed Engl; 2023 May; 62(20):e202303097. PubMed ID: 36924324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Charge-switchable polymeric complex for glucose-responsive insulin delivery in mice and pigs.
    Wang J; Yu J; Zhang Y; Zhang X; Kahkoska AR; Chen G; Wang Z; Sun W; Cai L; Chen Z; Qian C; Shen Q; Khademhosseini A; Buse JB; Gu Z
    Sci Adv; 2019 Jul; 5(7):eaaw4357. PubMed ID: 31309150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Engineered Nanosugar Enables Rapid and Sustained Glucose-Responsive Insulin Delivery in Diabetic Mice.
    Xu R; Bhangu SK; Sourris KC; Vanni D; Sani MA; Karas JA; Alt K; Niego B; Ale A; Besford QA; Dyett B; Patrick J; Carmichael I; Shaw JE; Caruso F; Cooper ME; Hagemeyer CE; Cavalieri F
    Adv Mater; 2023 May; 35(21):e2210392. PubMed ID: 36908046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-Responsive Nanoparticles for Rapid and Extended Self-Regulated Insulin Delivery.
    Volpatti LR; Matranga MA; Cortinas AB; Delcassian D; Daniel KB; Langer R; Anderson DG
    ACS Nano; 2020 Jan; 14(1):488-497. PubMed ID: 31765558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose sensitive konjac glucomannan/concanavalin A nanoparticles as oral insulin delivery system.
    Xu M; Huang J; Jiang S; He J; Wang Z; Qin H; Guan YQ
    Int J Biol Macromol; 2022 Mar; 202():296-308. PubMed ID: 35038475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glucose-responsive insulin patch for the regulation of blood glucose in mice and minipigs.
    Yu J; Wang J; Zhang Y; Chen G; Mao W; Ye Y; Kahkoska AR; Buse JB; Langer R; Gu Z
    Nat Biomed Eng; 2020 May; 4(5):499-506. PubMed ID: 32015407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin.
    Yu F; Li Y; Liu CS; Chen Q; Wang GH; Guo W; Wu XE; Li DH; Wu WD; Chen XD
    Int J Pharm; 2015 Apr; 484(1-2):181-91. PubMed ID: 25724135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microgel encapsulated nanoparticles for glucose-responsive insulin delivery.
    Volpatti LR; Facklam AL; Cortinas AB; Lu YC; Matranga MA; MacIsaac C; Hill MC; Langer R; Anderson DG
    Biomaterials; 2021 Jan; 267():120458. PubMed ID: 33197650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose-responsive microneedle patch for closed-loop dual-hormone delivery in mice and pigs.
    Yang C; Sheng T; Hou W; Zhang J; Cheng L; Wang H; Liu W; Wang S; Yu X; Zhang Y; Yu J; Gu Z
    Sci Adv; 2022 Dec; 8(48):eadd3197. PubMed ID: 36449622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic enzyme-based nanoparticles act as smart catalyst for glucose responsive release of insulin.
    Jana BA; Shinde U; Wadhwani A
    J Biotechnol; 2020 Dec; 324():1-6. PubMed ID: 32987063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, in vitro and in vivo evaluation of PLGA/Chitosan based nano-complex as a novel insulin delivery formulation.
    Mohammadpour F; Hadizadeh F; Tafaghodi M; Sadri K; Mohammadpour AH; Kalani MR; Gholami L; Mahmoudi A; Chamani J
    Int J Pharm; 2019 Dec; 572():118710. PubMed ID: 31629731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery.
    Wang J; Wang Z; Chen G; Wang Y; Ci T; Li H; Liu X; Zhou D; Kahkoska AR; Zhou Z; Meng H; Buse JB; Gu Z
    ACS Nano; 2021 Mar; 15(3):4294-4304. PubMed ID: 33685124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocyte-Membrane-Enveloped Biomineralized Metal-Organic Framework Nanoparticles Enable Intravenous Glucose-Responsive Insulin Delivery.
    He M; Yu P; Hu Y; Zhang J; He M; Nie C; Chu X
    ACS Appl Mater Interfaces; 2021 May; 13(17):19648-19659. PubMed ID: 33890785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-Regulated Carboxyphenylboronic Acid-Modified Mesoporous Silica Nanoparticles with "Touch Switch" Releasing Property for Insulin Delivery.
    Hou L; Zheng Y; Wang Y; Hu Y; Shi J; Liu Q; Zhang H; Zhang Z
    ACS Appl Mater Interfaces; 2018 Jul; 10(26):21927-21938. PubMed ID: 29932320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered insulin-polycation complexes for glucose-responsive delivery with high insulin loading.
    Volpatti LR; Burns DM; Basu A; Langer R; Anderson DG
    J Control Release; 2021 Oct; 338():71-79. PubMed ID: 34391834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On-demand transdermal insulin delivery system for type 1 diabetes therapy with no hypoglycemia risks.
    Fu Y; Liu P; Chen M; Jin T; Wu H; Hei M; Wang C; Xu Y; Qian X; Zhu W
    J Colloid Interface Sci; 2022 Jan; 605():582-591. PubMed ID: 34343731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microneedle Patches Loaded with Nanovesicles for Glucose Transporter-Mediated Insulin Delivery.
    Chen Q; Xiao Z; Wang C; Chen G; Zhang Y; Zhang X; Han X; Wang J; Ye X; Prausnitz MR; Li S; Gu Z
    ACS Nano; 2022 Nov; 16(11):18223-18231. PubMed ID: 36322923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose and H
    Xu X; Ran Y; Huang C; Yin Z
    Biomacromolecules; 2022 Apr; 23(4):1765-1776. PubMed ID: 35275618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of glucose oxidase-immobilized alginate nanoparticles for enhanced glucose-triggered insulin delivery in diabetic mice.
    Chai Z; Dong H; Sun X; Fan Y; Wang Y; Huang F
    Int J Biol Macromol; 2020 Sep; 159():640-647. PubMed ID: 32428589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycopolymer Nanoparticles with On-Demand Glucose-Responsive Insulin Delivery and Low-Hypoglycemia Risks for Type 1 Diabetic Treatment.
    Fu Y; Sun Y; Chen M; Xing W; Xu Y; Qian X; Zhu W
    Biomacromolecules; 2022 Mar; 23(3):1251-1258. PubMed ID: 35084834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.